Neutrophils as emerging therapeutic targets
Neutrophils are the most abundant circulating leukocytes, being the first line of defence
against bacterial and fungal infections. However, neutrophils also contribute to tissue …
against bacterial and fungal infections. However, neutrophils also contribute to tissue …
[HTML][HTML] Neutrophils as emerging protagonists and targets in chronic inflammatory diseases
K Rawat, A Shrivastava - Inflammation Research, 2022 - Springer
Introduction Neutrophils are the key cells of our innate immune system with a primary role in
host defense. They rapidly arrive at the site of infection and display a range of effector …
host defense. They rapidly arrive at the site of infection and display a range of effector …
[HTML][HTML] Targeting neutrophils for promoting the resolution of inflammation
JG Filep - Frontiers in immunology, 2022 - frontiersin.org
Acute inflammation is a localized and self-limited innate host-defense mechanism against
invading pathogens and tissue injury. Neutrophils, the most abundant immune cells in …
invading pathogens and tissue injury. Neutrophils, the most abundant immune cells in …
Rational targeting of immunosuppressive neutrophils in cancer
Y Zhao, S Rahmy, Z Liu, C Zhang, X Lu - Pharmacology & Therapeutics, 2020 - Elsevier
Neutrophils, the most abundant circulating leukocytes in human, play an indispensable role
in the innate immune response to microbial infections. However, the contribution of tumor …
in the innate immune response to microbial infections. However, the contribution of tumor …
Neutrophils as protagonists and targets in chronic inflammation
O Soehnlein, S Steffens, A Hidalgo… - Nature Reviews …, 2017 - nature.com
Traditionally, neutrophils have been acknowledged to be the first immune cells that are
recruited to an inflamed tissue and have mainly been considered in the context of acute …
recruited to an inflamed tissue and have mainly been considered in the context of acute …
[HTML][HTML] Plasticity in pro-and anti-tumor activity of neutrophils: shifting the balance
C Furumaya, P Martinez-Sanz, P Bouti… - Frontiers in …, 2020 - frontiersin.org
Over the last decades, cancer immunotherapies such as checkpoint blockade and adoptive
T cell transfer have been a game changer in many aspects and have improved the treatment …
T cell transfer have been a game changer in many aspects and have improved the treatment …
[HTML][HTML] Neutrophil heterogeneity as therapeutic opportunity in immune-mediated disease
R Grieshaber-Bouyer, PA Nigrovic - Frontiers in immunology, 2019 - frontiersin.org
Neutrophils are versatile innate effector cells essential for immune defense but also
responsible for pathologic inflammation. This dual role complicates therapeutic targeting …
responsible for pathologic inflammation. This dual role complicates therapeutic targeting …
[HTML][HTML] Neutrophils as a therapeutic target in cancer
Z Granot - Frontiers in immunology, 2019 - frontiersin.org
Neutrophils are the most abundant population of white blood cells in the human circulation.
They are terminally differentiated myeloid cells which were traditionally associated with …
They are terminally differentiated myeloid cells which were traditionally associated with …
[HTML][HTML] Neutrophil heterogeneity in cancer: from biology to therapies
P Lecot, M Sarabi, M Pereira Abrantes… - Frontiers in …, 2019 - frontiersin.org
Neutrophils have been extensively described in the pathophysiology of autoimmune and
infectious diseases. Accumulating evidence also suggests the important role of neutrophils …
infectious diseases. Accumulating evidence also suggests the important role of neutrophils …
Neutrophils in the activation and regulation of innate and adaptive immunity
A Mantovani, MA Cassatella, C Costantini… - Nature reviews …, 2011 - nature.com
Neutrophils have long been viewed as the final effector cells of an acute inflammatory
response, with a primary role in the clearance of extracellular pathogens. However, more …
response, with a primary role in the clearance of extracellular pathogens. However, more …